Dr Dawn A Miura, MD | |
98-1079 Moanalua Rd, Suite 350, Aiea, HI 96701-4713 | |
(808) 487-2277 | |
(808) 488-5582 |
Full Name | Dr Dawn A Miura |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 37 Years |
Location | 98-1079 Moanalua Rd, Aiea, Hawaii |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003824160 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 7580 (Hawaii) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Pali Momi Medical Center | Aiea, HI | Hospital |
Straub Clinic And Hospital | Honolulu, HI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Straub Clinic And Hospital | 6305759754 | 404 |
News Archive
Urinary tract infections (UTIs) are among the most common infections, and they tend to come back again and again, even when treated. Most UTIs are caused by E. coli that live in the gut and spread to the urinary tract.
Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today that it has completed license agreements with key Norwegian cancer researchers. The agreements allow OvaGene to validate two new promising genomic technologies with the intention of developing these into clinical laboratory tests.
Two million infants die within 24 hours of birth each year and almost nine million children died before the age of 5 in 2008, according to a report by Save the Children, which says it would take $40 billion annually to "dramatically" cut these numbers, Agence France-Presse reports (Mohiuddin, 10/5).
Talecris Biotherapeutics announced today the publication of combined data from two studies demonstrating that augmentation therapy with Alpha(1)-Proteinase Inhibitor (Human) (A1PI) significantly reduces lung tissue loss in patients with emphysema related to Alpha(1)-antitrypsin (AAT) deficiency.
› Verified 8 days ago
Entity Name | Straub Clinic & Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457306508 PECOS PAC ID: 6305759754 Enrollment ID: O20031111000417 |
News Archive
Urinary tract infections (UTIs) are among the most common infections, and they tend to come back again and again, even when treated. Most UTIs are caused by E. coli that live in the gut and spread to the urinary tract.
Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today that it has completed license agreements with key Norwegian cancer researchers. The agreements allow OvaGene to validate two new promising genomic technologies with the intention of developing these into clinical laboratory tests.
Two million infants die within 24 hours of birth each year and almost nine million children died before the age of 5 in 2008, according to a report by Save the Children, which says it would take $40 billion annually to "dramatically" cut these numbers, Agence France-Presse reports (Mohiuddin, 10/5).
Talecris Biotherapeutics announced today the publication of combined data from two studies demonstrating that augmentation therapy with Alpha(1)-Proteinase Inhibitor (Human) (A1PI) significantly reduces lung tissue loss in patients with emphysema related to Alpha(1)-antitrypsin (AAT) deficiency.
› Verified 8 days ago
Entity Name | Aiea Internal Medicine Services, L.l.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598773657 PECOS PAC ID: 6305737172 Enrollment ID: O20040322001277 |
News Archive
Urinary tract infections (UTIs) are among the most common infections, and they tend to come back again and again, even when treated. Most UTIs are caused by E. coli that live in the gut and spread to the urinary tract.
Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today that it has completed license agreements with key Norwegian cancer researchers. The agreements allow OvaGene to validate two new promising genomic technologies with the intention of developing these into clinical laboratory tests.
Two million infants die within 24 hours of birth each year and almost nine million children died before the age of 5 in 2008, according to a report by Save the Children, which says it would take $40 billion annually to "dramatically" cut these numbers, Agence France-Presse reports (Mohiuddin, 10/5).
Talecris Biotherapeutics announced today the publication of combined data from two studies demonstrating that augmentation therapy with Alpha(1)-Proteinase Inhibitor (Human) (A1PI) significantly reduces lung tissue loss in patients with emphysema related to Alpha(1)-antitrypsin (AAT) deficiency.
› Verified 8 days ago
Entity Name | Dawn A Miura Md Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316667835 PECOS PAC ID: 7810367315 Enrollment ID: O20221227001634 |
News Archive
Urinary tract infections (UTIs) are among the most common infections, and they tend to come back again and again, even when treated. Most UTIs are caused by E. coli that live in the gut and spread to the urinary tract.
Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today that it has completed license agreements with key Norwegian cancer researchers. The agreements allow OvaGene to validate two new promising genomic technologies with the intention of developing these into clinical laboratory tests.
Two million infants die within 24 hours of birth each year and almost nine million children died before the age of 5 in 2008, according to a report by Save the Children, which says it would take $40 billion annually to "dramatically" cut these numbers, Agence France-Presse reports (Mohiuddin, 10/5).
Talecris Biotherapeutics announced today the publication of combined data from two studies demonstrating that augmentation therapy with Alpha(1)-Proteinase Inhibitor (Human) (A1PI) significantly reduces lung tissue loss in patients with emphysema related to Alpha(1)-antitrypsin (AAT) deficiency.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Dawn A Miura, MD 98-1079 Moanalua Rd, Suite 350, Aiea, HI 96701-4713 Ph: (808) 487-2277 | Dr Dawn A Miura, MD 98-1079 Moanalua Rd, Suite 350, Aiea, HI 96701-4713 Ph: (808) 487-2277 |
News Archive
Urinary tract infections (UTIs) are among the most common infections, and they tend to come back again and again, even when treated. Most UTIs are caused by E. coli that live in the gut and spread to the urinary tract.
Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.
OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today that it has completed license agreements with key Norwegian cancer researchers. The agreements allow OvaGene to validate two new promising genomic technologies with the intention of developing these into clinical laboratory tests.
Two million infants die within 24 hours of birth each year and almost nine million children died before the age of 5 in 2008, according to a report by Save the Children, which says it would take $40 billion annually to "dramatically" cut these numbers, Agence France-Presse reports (Mohiuddin, 10/5).
Talecris Biotherapeutics announced today the publication of combined data from two studies demonstrating that augmentation therapy with Alpha(1)-Proteinase Inhibitor (Human) (A1PI) significantly reduces lung tissue loss in patients with emphysema related to Alpha(1)-antitrypsin (AAT) deficiency.
› Verified 8 days ago
Dr. Michael Wayne Chan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Suite 655, Aiea, HI 96701 Phone: 808-486-6200 | |
Dr. Craig Yoshio Hamasaki, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 98-1247 Kaahumanu Street, Suite 224, Aiea, HI 96701 Phone: 808-486-9119 Fax: 808-486-9401 | |
Dr. Kevin Scott Hara, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Suite 430, Aiea, HI 96701 Phone: 808-484-2000 Fax: 808-488-6580 | |
Shayne Mark Castanera, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 808-486-6000 | |
Dr. Ky H Le, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 98-199 Kamehameha Hwy Unit C-10b, Aiea, HI 96701 Phone: 808-954-4500 Fax: 808-758-0146 | |
Dr. Malissa Hyun Kyung Iida-takashima, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Ste 500, Aiea, HI 96701 Phone: 808-488-0990 |